i) at it's current stage of progress, how long do you anticipate before the DurAVR can be sold in Australia, in Europe and in The US assuming all goes well with future trials and regulatory approval procedures.
ii) From the feedback you (Mr Paterson) have received from our advisory board will all/the majority be looking to use DurAVR as immediately as it's approved in their relevant jurisdictions.
iii) Within a margin of error of a hundred or so how many TAVR procedures did our advisory board collectively do in CY2021.
Considering the questions will be submitted previously I believe all questions are viable and of significant interest to current/prospective investors!
Thanks again.
AVR Price at posting:
$17.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)